SCHEMBL716409

SCHEMBL716409

OCC1OCCCO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17443154 0.93
SCHEMBL714076 0.86
SCHEMBL15435355 0.86
SCHEMBL10831461 0.77 LMNA (0.39)
SCHEMBL31558054 0.76
SCHEMBL3457354 0.76 TSHR (0.33)
SCHEMBL18282347 0.76 TSHR (0.33)
SCHEMBL2430959 0.75
SCHEMBL1840595 0.73
SCHEMBL27873763 0.73 NLRP3 (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122080378-A High-crystallinity furyl polyester, and preparation method and application thereof 2026-05-26 CN claimed
CN-121512877-B Instant anti-wrinkle polypeptide composition and preparation method and application thereof 杭州湃肽生化科技有限公司 2026-05-15 CN claimed
CN-111944567-B High-calorific-value environment-friendly combustion oil 汕尾市南风新能源环保科技有限公司 2022-09-16 CN claimed
EP-1228059-B1 NOVEL CYCLOPROPANES AS CGRP ANTAGONISTS, MEDICAMENTS CONTAINING SAID COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF BOEHRINGER INGELHEIM PHARMA (DE) 2005-08-03 EP claimed
CN-122080378-A High-crystallinity furyl polyester, and preparation method and application thereof 2026-05-26 CN disclosed
CN-121512877-B Instant anti-wrinkle polypeptide composition and preparation method and application thereof 杭州湃肽生化科技有限公司 2026-05-15 CN disclosed
CN-119764555-A Annular ether electrolyte for alkali metal battery, preparation method of annular ether electrolyte and alkali metal battery 池州聚石化学有限公司 2025-04-04 CN disclosed
CN-119118819-A Method and device for co-producing formic acid and by-product diethylene glycol from ethylene glycol 北京化工大学 2024-12-13 CN disclosed
EP-4472982-A1 PROCESSES FOR THE PREPARATION OF SELECTIVE ESTROGEN RECEPTOR DEGRADERS Eli Lilly and Company (US) 2024-12-11 EP disclosed
CN-118647619-A Process for preparing selective estrogen receptor degrading agent 伊莱利利公司 2024-09-13 CN disclosed
US-20240199629-A1 PROCESSES FOR THE PREPARATION OF SELECTIVE ESTROGEN RECEPTOR DEGRADERS ELI LILLY AND COMPANY 2024-06-20 US disclosed
CN-115636722-B Preparation method of ethylene glycol 中国石油天然气股份有限公司 2024-04-30 CN disclosed
WO-2006066414-A1 HYDROXYDIHYDROPYRIDOPY RAZINE-1,8-DIONES AND METHODS FOR INHIBITING HIV INTEGRASE VIROCHEM PHARMA INC. (CA) 2006-06-29 WO disclosed
EP-1672626-A1 OPTICAL RECORDING MEDIUM AND COMPOUND USED IN THE OPTICAL RECORDING MEDIUM Mitsui Chemicals, Inc. (JP) 2006-06-21 EP disclosed
US-20050267137-A1 Cyclopropane CGRP antagonists, medicaments containing these compounds, and method for the production thereof BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2005-12-01 US disclosed
US-6693222-B2 HYDRATING ACROLEIN USING ACID CATALYST, CATALYTICALLY HYDROGENATING PRODUCT, REFINING MIXTURE CONTAINING WATER, 1,3-PROPANEDIOL AND HIGH BOILING BY-PRODUCTS, TREATING BOILER SUMP IN AQUEOUS SOLUTION WITH ACID CATALYST, NEUTRALIZING E. I. DU PONT DE NEMOURS AND COMPANY 2004-02-17 US disclosed
US-20030139417-A1 Cyclopropane CGRP antagonists, medicaments containing these compounds, and method for the production thereof BOEHRINGER INGELHEIM PHARMA KG (DE) 2003-07-24 US disclosed
EP-0247472-A2 Process for the preparation of carboxylic acid derivatives BAYER AG (DE) 1987-12-02 EP disclosed
US-4342681-A Use of organic silicon compounds in combination with oxetane compounds, dioxanes or tetrahydrofuranes for stabilizing and brightening polycarbonates which are free from phosphites and free from boric acid esters BAYER AKTIENGESELLSCHAFT (DE) 1982-08-03 US disclosed
EP-0019217-A1 Use of organic silicium compounds in combination with oxetane compounds, dioxanes or tetrahydrofuranes for the stabilisation and brightening of polycarbonates free from phosphites and boric acid esters BAYER AG (DE) 1980-11-26 EP disclosed